Artiva Biotherapeutics is a clinical-stage biotechnology company dedicated to developing natural killer (NK) cell-based therapies aimed at treating severe autoimmune diseases. Our innovative lead product, AlloNK®, is a non-genetically modified, cryopreserved NK cell therapy designed for use alongside B-cell targeted monoclonal antibodies, offering efficient and accessible treatment options in community settings.
No jobs found. Subscribe below to get notified when we find something for you.
Searching
Companies
Want job alerts that match your preferences?
Set up job preferences →